Latest news about Choksi Laboratories
Choksi Laboratories
121.00
+13.90(+12.98%)
Company Performance:
View Company Insights1D+12.98%
1M+17.48%
6M-13.17%
1Y+7.08%
5Y+1,173.68%
More news about Choksi Laboratories
07Apr 26
Choksi Laboratories Submits Q4FY26 Compliance Certificate Under SEBI Regulation 74(5)
Choksi Laboratories Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on 07-04-2026. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper handling of securities dematerialisation processes during the quarter ended 31st March 2026. The submission demonstrates the company's adherence to regulatory requirements for depository participant processes and securities handling.
27Mar 26
Choksi Laboratories Publishes Postal Ballot Notice for Director Appointment
Choksi Laboratories Limited has completed newspaper publication requirements for its postal ballot notice regarding the appointment of Mr. Ritik Pavecha as Non-Executive Independent Director. The company published confirmation in Free Press Journal and Choutha Sansar on March 27, 2026, with e-voting scheduled from March 28 to April 26, 2026.
09Feb 26
Choksi Laboratories Publishes Q3FY26 Results in Newspapers, Completes Regulatory Filing
Choksi Laboratories has completed the mandatory newspaper publication of its Q3FY26 financial results in Free Press Journal and Choutha Sansar on February 8, 2026, following SEBI regulatory requirements. The company demonstrated strong financial performance with revenue growth of 4.24% and significant net profit increase of 193.29%, while also implementing board leadership changes with the appointment of Mr. Ritik Pavecha as Additional Non-Executive Independent Director.
07Feb 26
Choksi Laboratories Reconstitutes Board Committees Following Director Changes
Choksi Laboratories Limited reconstituted its Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee on February 07, 2026. The changes followed Mrs. Meenaxi Patidar's resignation as Non-Executive Independent Director on January 09, 2026, and the subsequent appointment of Mr. Ritik Pavecha as additional Non-Executive Independent Director. All committees now comprise independent directors in compliance with SEBI listing regulations and Companies Act requirements.
10Jan 26
Choksi Laboratories Independent Director Mrs. Meenaxi Patidar Resigns Due to Personal Commitments
Mrs. Meenaxi Patidar resigned as Non-Executive Independent Director of Choksi Laboratories Limited effective January 09, 2026, due to preoccupation and personal commitments. Her departure also resulted in her ceasing roles as Audit Committee Member and Chairperson of the Nomination & Remuneration Committee. The company has completed all required regulatory disclosures under SEBI regulations, with Mrs. Patidar confirming no other material reasons for her resignation.
13Aug 25
Choksi Laboratories Reappoints Vyangesh Choksi as Whole Time Director for Five-Year Term
Choksi Laboratories Limited has announced the reappointment of Vyangesh Choksi as Whole Time Director for a five-year term from September 1, 2025, to August 31, 2030, subject to shareholder approval. The decision was made during a board meeting on August 13, 2025. The company also approved financial results, set the date for the 32nd AGM, and made auditor appointments. Vyangesh Choksi is part of the promoter family, with other family members holding key positions in the company.
Industry Peers
Dr. Lal Path Labs
Vijaya Diagnostic Centre
Metropolis Healthcare
Thyrocare Technologies
Nephrocare Health Services
Krsnaa Diagnostics
Suraksha Diagnostic
3B BlackBio DX
Health X Platform
One Global Service Provider
1,668.60
(-2.06%)
1,271.70
(-2.18%)
518.30
(+1.95%)
475.25
(+0.98%)
614.10
(-5.48%)
562.80
(-0.62%)
305.05
(+1.85%)
1,263.00
(-0.52%)
288.15
(+0.93%)
459.75
(+4.99%)
Get More Market Insights with
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
